P. Heaton

To our wonderful peer reviewers and authors: Thank you!
20230 citationsauthor #1
Pharmacy residents improve public health!
20230 citationsauthor #1
Pharmacy residents increase access to health care!
20220 citationsauthor #1
Development of a visual abstract template to enhance journal article circulation on social media.
20222 citationsauthor #2
2022-A year of imagination.
20220 citationsauthor #1
JAPhA-We are all in!
20220 citationsauthor #1
Peer reviewers and authors: Thank you!
20220 citationsauthor #1
Physician-approved protocols increase naloxone dispensing rates
20212 citationsauthor #6
Differential Cost-Sharing Undermines Treatment Adherence to Combination Therapy: Evidence from Diabetes Treatment
20216 citationsauthor #2
Authors and Peer-Reviewers: Our Foundation.
20210 citationsauthor #1
Pharmacy residents have grit!
20210 citationsauthor #1
The impact of community pharmacy utilization of immunization information systems on vaccination rates: Results of a clustered randomized controlled trial.
20219 citationsauthor #1
JAPhA-New beginnings 2020.
20200 citationsauthor #1
Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates
202021 citationsauthor #10
Peer reviewers: Our hidden heroes.
20200 citationsauthor #1
Community-based residency programs: Practice without limits.
20200 citationsauthor #1
Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study.
20205 citationsauthor #3
Marked Variation Exists Among Surgeons and Hospitals in the Use of Secondary Cleft Lip Surgery
20209 citationsauthor #4
2021 - A year of hope.
20200 citationsauthor #1
JAPhA: Publishing the evidence to advance pharmacy
20190 citationsauthor #1
CEOR_A_205597 713..727
20190 citationsauthor #3
Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
20195 citationsauthor #4
Improving care transitions through medication therapy management: A community partnership to reduce readmissions in multiple health-systems.
201929 citationsauthor #1
Assessment of community pharmacists' confidence, foundational knowledge, and coordination of care activities in patients with cancer as a chronic condition.
20194 citationsauthor #3
Poverty, Transportation Access, and Medication Nonadherence
201851 citationsauthor #2
An appointment-based model to systematically assess and administer vaccinations.
201811 citationsauthor #3
Community-based pharmacy residents: Transforming the health care landscape.
20181 citationsauthor #1
Five-Fold Variation Among Surgeons and Hospitals in the Use of Secondary Palate Surgery
201821 citationsauthor #3
Appointment-based models: A comparison of three model designs in a large chain community pharmacy setting.
201823 citationsauthor #6
Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic.
20188 citationsauthor #5
Variation among cleft centres in the use of secondary surgery for children with cleft palate: a retrospective cohort study
20178 citationsauthor #4
Community-based pharmacy residents: Engaged at the intersection of health and medication needs.
20172 citationsauthor #1
Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation
20178 citationsauthor #7
National Estimates of and Risk Factors for Inpatient Revision Surgeries for Orofacial Clefts
201738 citationsauthor #2
RELATIONSHIPS BETWEEN PATIENT SATISFACTION AND PHYSICAL AND MENTAL DOMAINS OF HEALTH STATUS
20170 citationsauthor #5
Clinical outcomes of switching from insulin glargine to NPH insulin in indigent patients at a charitable pharmacy: The Charitable Insulin NPH: Care for the Indigent study.
20174 citationsauthor #3
GENERIC DRUG DISCOUNT PROGRAMS AND THEIR POTENTIAL IMPACT ON BARRIERS TO ACCESS IN PATIENTS WITH DIABETES OR HYPERTENSION
20160 citationsauthor #2
Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System
201619 citationsauthor #4
Comparative Effectiveness of Tacrolimus-Based Steroid Sparing Versus Steroid Maintenance Regimens in Patients with Kidney Transplantation: Results from a Discrete Event Simulation
20160 citationsauthor #7
Twenty years of triptans in the United States Medicaid programs: Utilization and reimbursement trends from 1993 to 2013
20167 citationsauthor #4
Health Beliefs Describing Patients Enrolling in Community Pharmacy Disease Management Programs
201619 citationsauthor #5
Utilization and Spending Trends for Pain Medications among Cancer Survivors in the United States: Results from Medical Expenditure Panel Survey
20161 citationsauthor #7
’ s response to reviews Title : Sulfonylurea Use and the Risk of Hospital Readmission in Patients with Type 2 Diabetes
20160 citationsauthor #1
RISK OF ACUTE LIVER INJURY ASSOCIATED WITH THE USE OF ORLISTAT: A COHORT STUDY USING THE MARKETSCAN® COMMERCIAL CLAIMS DATABASE
20160 citationsauthor #4
Prescribing Patterns For Patients With Prostate Cancer In The United States: 2006-2010
20160 citationsauthor #3
Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
201620 citationsauthor #5
Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
201619 citationsauthor #1
TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
201594 citationsauthor #9
Student pharmacists' perceptions of access to student organization opportunities at colleges/schools of pharmacy with satellite campuses
20154 citationsauthor #3
Urinary Tract Infection Among the sglt 2 Inhibitors: a Meta-Analysis of 19 Randomized controlled trials
20151 citationsauthor #3
Geographical accessibility to Community and Hospital Pharmacies in Hamilton County
20151 citationsauthor #4
Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes.
20158 citationsauthor #5
Cross-state comparison of medicaid Anti-Obesity medication coverage: 1999-2013
20150 citationsauthor #3
Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010
201584 citationsauthor #5
The Pharmacy-Level Asthma Medication Ratio and Population Health
201517 citationsauthor #5
Validation and u.s. Population norms of health-related productivity questionnaire
201517 citationsauthor #7
Generic Drug Discount Programs And Their Potential Impact On The Completeness Of Pharmacy Claims Data
20150 citationsauthor #3
National Estimates Of Primary And Secondary Cleft Palate Surgery: Results From The Kids’ Inpatient Database
20141 citationsauthor #2
Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010
20146 citationsauthor #4
Efficacy Of Phentermine Monotherapy, Topiramate Monotherapy, And Phentermine/Topiramate Combination Therapy On Weight Loss: A Network Meta-Analysis Of Randomized Controlled Trial Data
20145 citationsauthor #2
Costs Of Delayed Graft Function After Kidney Transplantation In Living And Deceased Donor Recipients
20140 citationsauthor #5
Medicare Annual Wellness Visits: patient need and pharmacist patient care services intersect.
20145 citationsauthor #1
Poster Sessions: Other
20140 citationsauthor #15
Cleft Lip Surgery: Results From The Kids’ Inpatient Database
20140 citationsauthor #2
Firm- and Drug-Specific Patterns of Generic Drug Payments by US Medicaid Programs: 1991–2008
201410 citationsauthor #7
Impact Of Bmi On Charges And Reimbursement In Kidney Transplant Hospitalization Of Deceased And Living Donor Recipients
20140 citationsauthor #4
Simvastatin And Its Potential Drug Interactions: An Analysis Of Safety Signal Based On Fda Aers Database
20140 citationsauthor #4
Obesity Incrementally Increases Charges in Kidney Transplantation.: Abstract# A452
20140 citationsauthor #9
Comparative Persistence on β-Blockers Versus Calcium Channel Blockers for Ventricular Rate Control in Nonelderly Patients With Atrial Fibrillation
20140 citationsauthor #6
The Effect Of FDA Risk Evaluation & Mitigation Strategies On Utilization Of Selected Drugs Using Data From Two National Surveys
20130 citationsauthor #2
Adaptation and application of the Agency for Healthcare Research and Quality's asthma admission rate pediatric quality indicator to Ohio Medicaid claims data.
20132 citationsauthor #4
The effect of electronic medical record system sophistication on preventive healthcare for women
201316 citationsauthor #6
Authors' response.
20130 citationsauthor #1
USE OF SULFONYLUREAS IS ASSOCIATED WITH HIGHER RISK OF READMISSION AMONG PATIENTS WITH TYPE 2 DIABETES
20130 citationsauthor #1
Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
201342 citationsauthor #4
U.S. emergency departments visits resulting from poor medication adherence: 2005-07.
201343 citationsauthor #1
Frequencies, Costs, and Complications of Catheter Ablation for Tachyarrhythmias in Children: 2000–2009
201317 citationsauthor #4
Impact Of Advanced Versus Basic Electronic-Medical-Record Systems On The Quality Of Patient Care: A Meta-Analysis Of 10 Randomized Controlled Trials
20130 citationsauthor #3
Characteristics of Social and Administrative Sciences graduate programs and strategies for student recruitment and future faculty development in the United States.
20138 citationsauthor #5
Staged palliation of hypoplastic left heart syndrome: trends in mortality, cost, and length of stay using a national database from 2000 through 2009.
201341 citationsauthor #3
Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population?
20132 citationsauthor #6
Cardiac rhythm devices in the pediatric population: utilization and complications.
201265 citationsauthor #6
Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
20125 citationsauthor #1
PCV27 Survival to Discharge After Cardiac Arrest in a Pediatric Population: Results from the Kids' Inpatient Database, 2003-2009 in the United States
20120 citationsauthor #2
PCV96 Trends in Utilization for Rate-Control and Rhythm-Control Drugs from 2001 to 2009: Results from the National Ambulatory Medical Care Survey
20120 citationsauthor #4
Postoperative Heart Block in Children with Common Forms of Congenital Heart Disease: Results from the KID Database
201260 citationsauthor #5
PDB44 Differences in Utilization of and Expenditures on Office-Based Health Care Between Uninsured and Insured Children 0-17 Years of Age From 2004-2008: Results From the Medical Expenditure Panel Survey
20120 citationsauthor #2
Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
201216 citationsauthor #5
UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs: 1991-2008
20120 citationsauthor #6
National Burden of Pediatric Hospitalizations for Inflammatory Bowel Disease: Results From the 2006 Kids’ Inpatient Database
201241 citationsauthor #1
Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
201230 citationsauthor #3
PDB103 Predictors of Hospital Readmissions in Patients With Diabetes: Results From the 1999-2009 Medical Expenditure Panel Survey
20120 citationsauthor #4
Pediatric syncope: National Hospital Ambulatory Medical Care Survey results.
201240 citationsauthor #6
PR3 Qualitative Assessment of Health-Related Productivity Instruments
20120 citationsauthor #2
Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office‐based settings
201249 citationsauthor #2
Impact of drug label changes on propofol use in pediatrics for moderate conscious sedation.
20114 citationsauthor #1
PMH67 CO-PRESCRIBING CHOLINESTERASE INHIBITORS WITH ANTICHOLINERGIC URINARY INCONTINENCE MEDICATIONS
20110 citationsauthor #2
PMH74 UTILIZATION, PRICE AND SPENDING TRENDS FOR SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS IN THE UNITED STATES MEDICAID PROGRAM: 1991-2009
20110 citationsauthor #5
PHP47 ADVERSE DRUG EVENTS AND ELECTRONIC MEDICAL RECORDS: RESULTS FROM THE 2007-2008 NATIONAL AMBULATORY MEDICAL CARE SURVEY
20110 citationsauthor #2
DU3 IMPACT OF THE FDA'S ANTIPSYCHOTIC BLACK BOX WARNING ON PSYCHOTROPIC DRUG PRESCRIBING IN ELDERLY PATIENTS WITH DEMENTIA IN OUTPATIENT AND OFFICE-BASED SETTINGS
20110 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT